Acutaas Chemicals Q4 PAT Soars 114% YoY to ₹1,343 Mn

Acutaas Chemicals reported Q4 FY26 revenue of ₹4,328 Mn, up 40.3% YoY, and PAT of ₹1,343 Mn, surging 114.1% YoY with a record 31.0% margin.
Full-year FY26 revenue grew 33.0% to ₹13,394 Mn, while PAT more than doubled to ₹3,564 Mn, driven by strong EBITDA margins and other income.
Management provided FY27 revenue growth guidance of 25%, focusing on diversified growth across Battery Chemicals, Semiconductors, and Pharmaceutical CDMO verticals.
The investor presentation was filed pursuant to SEBI Listing Regulations and includes detailed financial statements and balance sheet updates as of March 31, 2026.